These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases. Kanzler S, Gerken G, Dienes HP, Meyer zum Büschenfelde KH, Lohse AW. Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991 [Abstract] [Full Text] [Related]
3. [Immunosuppressive treatment of chronic active hepatitis (author's transl)]. Vido I, Ranft U, Schmidt FW. Dtsch Med Wochenschr; 1980 Aug 29; 105(35):1205-9. PubMed ID: 7428636 [Abstract] [Full Text] [Related]
4. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation. Gibelli NE, Tannuri U, Mello ES, Cançado ER, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Pinho-Apezzato ML, Maksoud JG. Pediatr Transplant; 2006 May 29; 10(3):371-6. PubMed ID: 16677364 [Abstract] [Full Text] [Related]
5. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F, Akarca US, Ersöz G, Karasu Z, Yüce G, Batur Y. Hepatogastroenterology; 2002 May 29; 49(47):1195-200. PubMed ID: 12239904 [Abstract] [Full Text] [Related]
6. Life-saving immunosuppressive treatment in severe autoimmune chronic active hepatitis. Maggiore G, Bernard O, Hadchouel M, Alagille D. J Pediatr Gastroenterol Nutr; 1985 Aug 29; 4(4):655-8. PubMed ID: 4032180 [Abstract] [Full Text] [Related]
7. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis. Abonyi M, Kisfaludy S, Szalay F. Acta Physiol Hung; 1984 Aug 29; 64(3-4):455-60. PubMed ID: 6397971 [Abstract] [Full Text] [Related]
9. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T. Hepatogastroenterology; 1998 Aug 29; 45(24):2282-94. PubMed ID: 9951911 [Abstract] [Full Text] [Related]
10. [Long-term prognosis of chronic B and C viral hepatitis]. Ohlen J, Liegl JM, Selmair H. Leber Magen Darm; 1995 Sep 29; 25(5):205-10. PubMed ID: 7500807 [Abstract] [Full Text] [Related]
11. [Value of puncture biopsy of the liver during diagnostic and follow-up examinations (clinical aspects, immunological markers, images) in chronic hepatitis]. Gonvers JJ. Schweiz Med Wochenschr; 1986 Aug 05; 116(31-32):1030-5. PubMed ID: 2428101 [Abstract] [Full Text] [Related]
12. Treatment of patients with chronic hepatitis using ursodeoxycholic acid. Nambu M, Iijima T. Trop Gastroenterol; 1993 Aug 05; 14(2):59-65. PubMed ID: 8291125 [Abstract] [Full Text] [Related]
13. [The role of liver biopsy in the diagnosis of autoimmune hepatitis]. Szabó Z. Orv Hetil; 2006 Sep 03; 147(35):1697-702. PubMed ID: 17051746 [Abstract] [Full Text] [Related]
16. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation]. Chen H, Huang XJ, Liu KY, Xu LP, Wang H, Liu DH, Lu J, Lu DP. Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3062-6. PubMed ID: 16324408 [Abstract] [Full Text] [Related]
19. Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report. Saeki R, Kaneko S, Terasaki S, Unoura M, Ogino H, Wakabayashi T, Kawara S, Nakanuma Y, Kobayashi K. Hepatogastroenterology; 1993 Oct 16; 40(5):499-501. PubMed ID: 8270244 [Abstract] [Full Text] [Related]
20. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis. Simpson KJ, Jones AL, Forbes Howie A, Hayes PC. Eur J Gastroenterol Hepatol; 1995 May 16; 7(5):455-60. PubMed ID: 7542148 [Abstract] [Full Text] [Related] Page: [Next] [New Search]